Klinické štúdie Astma v štáte Pennsylvania
11 štúdií pre Astma hľadá účastníkov v zariadeniach v štáte Pennsylvania.
Mestá v štáte Pennsylvania
Oficiálny text štúdie (anglicky)
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Philadelphia
- Research Site, Smithfield
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06932263A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- University of Pittsburgh Medical Center, Pittsburgh
- Allergy and Clinical Immunology Associates, Pittsburgh
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07219173A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research Associates of Central PA, LLC, DuBois
Prebieha náborFáza 2
Vek 18 až 70 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06977581A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12072, Philadelphia
- Teva Investigational Site 12114, Pittsburgh
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT06664619A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, DuBois
- GSK Investigational Site, Wyomissing
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Pittsburgh
Prebieha náborFáza 3
Vek 12 až 17 · Všetky pohlavia · Aktualizované 13. 8. 2026 · NCT06307665Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT04743791A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Pittsburgh
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07532265Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 7. 2026 · NCT06979323A Study of CDX-622 in Participants With Mild to Moderate Asthma
- University of Pittsburgh Asthma and Environmental Lung Health Institute at UPMC, Pittsburgh
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 7. 2026 · NCT07330778Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 8 až 70 · Všetky pohlavia · Aktualizované 24. 10. 2025 · NCT06512064Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.